Apoptosis is a regulated form of cell death that plays a crucial role in maintaining tissue homeostasis and is increasingly recognized in cancer research. It is characterized by the formation of membrane-bound apoptotic bodies, which are phagocytosed without causing inflammation. Apoptosis is distinct from necrosis, which involves cell swelling and membrane rupture. Biochemically, apoptosis is marked by the internucleosomal cleavage of DNA, producing a characteristic "ladder" pattern on agarose gels. Apoptosis occurs spontaneously in many tumors, often inhibiting their growth, and is enhanced by treatments such as radiation, chemotherapy, and hormone ablation. The regulation of apoptosis is influenced by proto-oncogenes like c-myc and bcl-2, as well as the tumor suppressor gene p53. c-myc can initiate apoptosis, while bcl-2 inhibits it. p53, when functional, can induce apoptosis in response to DNA damage, and its loss is associated with tumor progression. Apoptosis is also induced by antibodies targeting the APO-1 or Fas receptors, suggesting potential therapeutic applications. Apoptosis is involved in normal tissue development and homeostasis, including the regression of the tadpole tail and removal of interdigital webs in embryos. In tumors, apoptosis can occur near necrotic regions and is influenced by factors such as tumor necrosis factor alpha and immune cell activity. Radiation, chemotherapy, hyperthermia, and hormone withdrawal can induce apoptosis, with varying effectiveness depending on the tumor type and treatment. Apoptosis is a key target for cancer therapy, as its regulation can influence tumor growth and response to treatment. Understanding the genetic and molecular mechanisms of apoptosis is essential for developing more effective cancer therapies.Apoptosis is a regulated form of cell death that plays a crucial role in maintaining tissue homeostasis and is increasingly recognized in cancer research. It is characterized by the formation of membrane-bound apoptotic bodies, which are phagocytosed without causing inflammation. Apoptosis is distinct from necrosis, which involves cell swelling and membrane rupture. Biochemically, apoptosis is marked by the internucleosomal cleavage of DNA, producing a characteristic "ladder" pattern on agarose gels. Apoptosis occurs spontaneously in many tumors, often inhibiting their growth, and is enhanced by treatments such as radiation, chemotherapy, and hormone ablation. The regulation of apoptosis is influenced by proto-oncogenes like c-myc and bcl-2, as well as the tumor suppressor gene p53. c-myc can initiate apoptosis, while bcl-2 inhibits it. p53, when functional, can induce apoptosis in response to DNA damage, and its loss is associated with tumor progression. Apoptosis is also induced by antibodies targeting the APO-1 or Fas receptors, suggesting potential therapeutic applications. Apoptosis is involved in normal tissue development and homeostasis, including the regression of the tadpole tail and removal of interdigital webs in embryos. In tumors, apoptosis can occur near necrotic regions and is influenced by factors such as tumor necrosis factor alpha and immune cell activity. Radiation, chemotherapy, hyperthermia, and hormone withdrawal can induce apoptosis, with varying effectiveness depending on the tumor type and treatment. Apoptosis is a key target for cancer therapy, as its regulation can influence tumor growth and response to treatment. Understanding the genetic and molecular mechanisms of apoptosis is essential for developing more effective cancer therapies.